Disability and quality of life in Charcot-Marie-Tooth disease type 1

Pfeiffer, G.; Wicklein, E. M.; Ratusinski, T.; Schmitt, L.; Kunze, K.
April 2001
Journal of Neurology, Neurosurgery & Psychiatry;Apr2001, p548
Academic Journal
No abstract available.


Related Articles

  • Depression and Charcot-Marie-Tooth disease. Vinci, P.; Gargiulo, P.; Colazza, G. B.; Padua, L.; Pazzaglia, C. // Neurological Sciences;Oct2007, Vol. 28 Issue 5, p295 

    Two letters to the editor are presented in response to the article "Variables influencing quality of life and disability in Charcot-Marie-Tooth (CMT) patients: Italian multicentre study."

  • Quality of Life in Children With Charcot-Marie-Tooth Disease. Burns, Joshua; Ryan, Monique M.; Ouvrier, Robert A. // Journal of Child Neurology;Mar2010, Vol. 25 Issue 3, p343 

    The authors studied the health-related quality of life of children aged 5 to 18 years with Charcot-Marie-Tooth disease of varying types and severity and compared it with the general pediatric population. To capture and compare the quality-of-life data across a broad range of ages, the Child...

  • Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4. Nicholson, Garth; Lenk, Guy M.; Reddel, Stephen W.; Grant, Adrienne E.; Towne, Charles F.; Ferguson, Cole J.; Simpson, Ericka; Scheuerle, Angela; Yasick, Michelle; Hoffman, Stuart; Blouin, Randall; Brandt, Carla; Coppola, Giovanni; Biesecker, Leslie G.; Batish, Sat D.; Meisler, Miriam H. // Brain: A Journal of Neurology;Jul2011, Vol. 134 Issue 7, p1959 

    Charcot–Marie–Tooth disease is a genetically heterogeneous group of motor and sensory neuropathies associated with mutations in more than 30 genes. Charcot–Marie–Tooth disease type 4J (OMIM 611228) is a recessive, potentially severe form of the disease caused by...

  • Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene. Vinci, Paolo; Lapi, Giovanni // Journal of Anaesthesiology Clinical Pharmacology;Apr2011, Vol. 27 Issue 2, p286 

    A letter to the editor about anesthetic management in Charcot-Marie-Tooth disease (CMT) type 2 attributed to a mutation in the mitofusin-2 gene is presented.

  • Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two generations. Panas, M.; Karadima, G.; Kalfakis, N.; Floroskufi, P.; Vassilopoulos, D. // Journal of Neurology;Apr2004, Vol. 251 Issue 4, p484 

    Presents a letter to the editor about Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two regions.

  • VyÅ¡etÅ™ení kardiovaskulární reaktivity u pacientů s dÄ›dičnou neuropatií. Horáček, O.; Jílková, D.; Matouš, M.; Mazanec, R.; Nedělka, J.; Kolář, P.; Nedělka, T. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;2014, Vol. 21 Issue 3, p130 

    The hereditary motor and sensitive neuropathy, morbus Charcot Marie Tooth, is one of the most common neuromuscular diseases in the world. In recent years a proofs suggesting, that illness has an autonomic component were found. On a group of 17 patients suffering from Charcot Marie Tooth disease...

  • Factors Associated With Foot and Ankle Strength in Healthy Preschool-Age Children and Age-Matched Cases of Charcot-Marie-Tooth Disease Type 1A. Rose, Kristy J.; Burns, Joshua; North, Kathryn N. // Journal of Child Neurology;Apr2010, Vol. 25 Issue 4, p463 

    Charcot-Marie-Tooth disease affects foot and ankle strength from the earliest stages of the disease; however, little is known about factors influencing normal strength development or the pathogenesis of foot weakness and deformity in Charcot-Marie-Tooth disease. The authors investigated factors...

  • Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Padua, L.; Aprile, I.; Cavallaro, T.; Commodari, I.; la Torre, G.; Pareyson, D.; Quattrone, A.; Rizzuto, N.; Vita, G.; Tonali, P.; Schenone, A. // Neurological Sciences;Dec2006, Vol. 27 Issue 6, p417 

    The purpose of this study was to assess the variables that influence quality of life (QoL) and disability in patients with Charcot-Marie-Tooth disease (CMT). We performed a prospective multicentre study using validated clinical disability and QoL measurements. Multivariate analysis was performed...

  • Charcot Marie Tooth Disease Type 1 - Rare but Commonest Hereditary Neuropathy. Bhattacharjee, Shakya; Saha, Shankar Prasad // Al Ameen Journal of Medical Sciences;2012, Vol. 5 Issue 1, p103 

    Objective: To present a case of Charcot Marie Tooth Disease. Backgrounds: A 22 years old boy presented with very slowly progressive symmetrical weakness of both lower limbs with distal muscular atrophy. He has a family member with similar problem. Methods: The patient was clinically examined and...

  • Obstructive sleep apnoea, restless leg syndrome and Charcot-Marie-Tooth disease type 1: important associations. Reilly, Mary M. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2014, Vol. 85 Issue 3, p245 

    The author discusses the association between obstructive sleep apnoea, restless leg syndrome (RLS) and Charcot-Marie-Tooth disease type 1 (CMT1). Topics discussed include the apnoea–hypopnoea index (AHI), the functional disability scale (FDS) and the neurological disability. The author...


Read the Article


Sign out of this library

Other Topics